Cochener Donna 4
4 · Neoleukin Therapeutics, Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Cochener Donna
General Counsel, SVP Legal
Transactions
- Award
Stock Option (Right to Buy)
2022-03-14+400,000→ 400,000 totalExercise: $1.81Exp: 2032-03-14→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total shares on March 14, 2023, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.